Nurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.
Mary Beth Seipel, PharmD, BCACP
Advertisement
Articles by Mary Beth Seipel, PharmD, BCACP
Advertisement
Latest Updated Articles
Overview of Nurtec ODT for Prevention of Episodic MigrainePublished: January 4th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
2
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
3
FDA Updates Boxed Warning for Cilta-Cel Following Reports of Immune Effector Cell–Associated Enterocolitis
4
Medetomidine: The Demon in the Illicit Fentanyl Supply
5
